Sonnendecker E W, de Souza J J, Herman A A
Br J Obstet Gynaecol. 1984 Feb;91(2):187-92. doi: 10.1111/j.1471-0528.1984.tb05905.x.
The association between pre-operative serum carcinoembryonic antigen (CEA) and liver scanning employing technetium (99mTc)-tin colloid was investigated in 30 women subsequently proven to have primary epithelial ovarian carcinoma to determine whether these two investigations improve the detection of hepatic metastases. The upper limit of normal for CEA (greater than or equal to 5 ng/ml) did not represent the optimal levels for use in predicting ovarian carcinoma nor the presence of liver metastases. But with CEA levels greater than 10 ng/ml sensitivity for liver metastases was 57%. Liver scanning alone demonstrated metastases in five out of seven patients (71%) with parenchymal liver metastases. The combination of CEA and liver scan was positive in six out of these seven patients (86%).
对30名后来被证实患有原发性上皮性卵巢癌的女性，研究了术前血清癌胚抗原（CEA）与使用锝（99mTc）-锡胶体进行肝脏扫描之间的关联，以确定这两项检查是否能提高肝转移的检测率。CEA的正常上限（大于或等于5 ng/ml）既不是预测卵巢癌的最佳水平，也不是存在肝转移的最佳水平。但当CEA水平大于10 ng/ml时，肝转移的敏感性为57%。仅肝脏扫描显示，7例有肝实质转移的患者中有5例（71%）出现转移。在这7例患者中，CEA与肝脏扫描联合检测有6例呈阳性（86%）。
